New Drug Approvals!
-Tremelimumab, the 2nd CTLA-4 inhibitor, finally gets approved.
-Teclistamab, an excited BCMA-CD3 T-cell engager for multiple myeloma.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
